Results 41 to 50 of about 5,207 (190)
ABSTRACT Background There is compelling evidence that treating high‐grade squamous intraepithelial lesions (HSIL), the anal squamous cell cancer (ASCC) precursor, reduces the risk of developing ASCC. Using high‐resolution anoscopy (HRA), surgical excision, ablative and topical therapies are widely used to treat HSIL.
Matthew Joseph Marino +5 more
wiley +1 more source
Among 211 prospectively followed Swiss patients with eosinophilic oesophagitis, chronic rhinosinusitis was two‐ to three‐fold more common than in the general population. It was associated with greater oesophageal symptom severity and, in a quarter of cases, was experienced by patients as more debilitating than the underlying oesophageal disease ...
Gebhardt Aidan +52 more
wiley +1 more source
Esófago de Barrett y su manejo Barrett's esophagus and its management
Se hace un recuento histórico del esófago de Barrett desde su descripción por Norman Barrett en 1950. Se discute la evolución del concepto. Se definen el esófago de Barrett corto y largo, su prevalencia y diagnóstico.
Mario Melguizo Bermúdez
doaj
Clinicopathologic Characteristics of Barrett's Cancer in Korea
Background/Aims: The incidence of Barrett's cancer is increasing in Western countries, but there have been only a few case reports of this condition in Korea. The aim of this study was to elucidate the endoscopic and pathologic characteristics of Barrett'
doaj +1 more source
Structured p53‐IHC in Barrett's oesophagus supports diagnostic decision‐making. In 1,146 cases, agreement between referring hospitals and the expert panel was moderate‐to‐substantial (κ = 0.61), with 24.2% of p53‐based classifications revised. Interobserver agreement among expert pathologists was substantial (κ = 0.65).
Ylva A. Weeda +17 more
wiley +1 more source
Multicentric Adenocarcinomas in a Long-Segment of Barrett's Esophagus
This report describes a complicated course of a 58-year-old patient with multicentric Barrett's carcinoma within a long-segment of Barrett metaplasia.
Stefan Hartl +2 more
doaj +1 more source
Cryotherapy versus radiofrequency ablation in the treatment of dysplastic Barrett’s esophagus with or without early esophageal neoplasia: a systematic review and meta-analysis [PDF]
Background/Aims Radiofrequency ablation (RFA) is the first-line therapy for dysplastic Barrett’s esophagus (BE). Therefore, cryotherapy has emerged as an alternative treatment option.
Igor Logetto Caetité Gomes +10 more
doaj +1 more source
ABSTRACT Background and Aim In Japan, gastric cancer (GC) and esophageal squamous cell carcinoma (ESCC) account for nearly all fatal upper gastrointestinal malignancies. A unified model that simultaneously predicts the incidence of these two cancers could help optimize endoscopic screening and postindex surveillance strategies.
Kenta Watanabe +26 more
wiley +1 more source
Buried Barrett’s Esophagus with High-Grade Dysplasia after Radiofrequency Ablation [PDF]
Radiofrequency ablation therapy is an effective endoscopic option for the eradication of Barrett’s esophagus that appears to reduce the risk of esophageal cancer.
Joana Castela +5 more
doaj +1 more source
Zebrafish provide a high‐throughput, optically transparent platform for cancer and drug screening. Their ~80% genetic homology, xenograft compatibility, and transgenic strains enable targeted photosensitizer screening, real‐time ROS and tumor imaging, and mechanistic assays, while fish embryo acute toxicity (FET) and in vitro tests streamline toxicity ...
Ethan Wilson +5 more
wiley +1 more source

